Evaluation of commercial veterinary probiotics containing enterococci for transferrable vancomycin resistance genes

13Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: Vancomycin resistant enterococci (VRE) are of significant public health concern. The identification of VRE in livestock and food has increased. The objective of this study was to determine if the transferrable vancomycin resistance genes vanA and vanB were present in probiotics marketed for use in animals that claimed to contain Enterococcus spp. Results: Of the 40 products selected, Enterococcus spp. DNA was successfully extracted from 36 products. Of these 36 products with enterococcal DNA, 2 (6%) had a PCR product consistent with vanA which was confirmed by sequencing. None of the products appeared to contain vanB.

Cite

CITATION STYLE

APA

Berreta, A., Baumgardner, R. M., & Kopper, J. J. (2020). Evaluation of commercial veterinary probiotics containing enterococci for transferrable vancomycin resistance genes. BMC Research Notes, 13(1). https://doi.org/10.1186/s13104-020-05114-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free